FTC sues pharmacy benefit managers for inflating price of insulin : …
WEB1 day ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB2 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB2 days ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
Federal Trade Commission sues largest drug middlemen for
WEB2 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB2 days ago · Sept. 20, 2024 Updated 3:16 p.m. ET. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of ...
FTC sues insulin middlemen, saying they pocket billions while …
WEB1 day ago · The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin. Search Query Show Search News
House lawmakers slam pharmacy middlemen over sky-high drug …
WEBJul 23, 2024 · WASHINGTON — Democratic and Republican lawmakers found common ground with one another at an oversight committee hearing Tuesday, blaming executives from three major pharmacy middlemen groups...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
FTC says prescription middlemen are squeezing Main Street ... - CBS News
WEBJul 9, 2024 · Prescription drug middlemen — also known as pharmacy benefit managers — are lining their pockets by inflating drug prices, including overcharging cancer patients, the Federal Trade Commission...